Kelly McCann, MD, PhD
![](https://education.binayfoundation.org/sites/default/files/styles/faculty_photo/public/faculty/2024-07/IMG_1202.jpeg?itok=vYFwPopi)
Kelly E. McCann, MD, PhD
Assistant Clinical Professor
Department of Medicine, Division of Hematology and Oncology
David Geffen School of Medicine at the University of California Los Angeles
Kelly E. McCann, MD, PhD, is an assistant clinical professor in the Division of Hematology/Oncology in the Department of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She graduated from Rice University in Houston, Texas, with a degree in biomedical engineering before enrolling in the medical scientist training program (MSTP) at Stanford University School of Medicine, where she earned her medical degree and a PhD in cancer biology studying DNA double-strand break repair by homologous recombination. She completed an internship and residency in Internal Medicine at Oregon Health & Science University (OHSU) in Portland and a fellowship in Hematology and Oncology at UCLA. Dr. McCann is board-certified in Internal Medicine, Hematology, and Oncology.
Dr. McCann is a breast oncologist specializing in translational breast cancer research. She is a member of UCLA’s Translational Oncology Research Laboratories (TORL) headed by Dr. Dennis Slamon and is an investigator on numerous clinical trials. She is a member of the American College of Physicians (ACP), the American Society of Clinical Oncology (ASCO), and the American Association for Cancer Research (AACR). Her work has been published in such peer-reviewed journals as Science, Bioinformatics, and Radiation Research.
Financial relationships
-
Attribution:SelfType of financial relationship:TravelIneligible company:Eli LillyTopic:Speaker's bureau for abemaciclibDate added:07/07/2024Date updated:07/07/2024